This is the authors' abstract. We don't add key points for this paper.
The rise in malignant melanoma incidence has been termed "epidemic". Closer scrutiny of epidemiologic data suggests overdiagnosis as the true cause of the dramatic rise in melanoma incidence. In epidemiologic terms, "overdiagnosis" describes lesions that are histologically malignant but biologically benign. Overdiagnosis is not unique to melanoma screening but is prevalent in screening for cancers of other organs, including the thyroid and prostate glands.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Earl J. Glusac (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: